Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pelvic Rehabilitation vs Trigger Point Injections for Dyspareunia
NCT02022722Phase 4Unknown
- Sponsor
- University of Cincinnati
- Start
- Aug 2013
- Primary completion
- Apr 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of triamcinolone acetonide, bupivacaine in dyspareunia, Pelvic floor myalgia (PFM), sponsored by University of Cincinnati. Status: unknown.
02
Drugs
triamcinolone acetonidebupivacaine
03
Conditions
dyspareuniaPelvic floor myalgia (PFM)
Beyond the preview
Go deeper on NCT02022722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02022722.